Published in Front Genet on May 01, 2013
Melanoma genetics/genomics. Front Oncol (2013) 0.75
Variance component model to account for sample structure in genome-wide association studies. Nat Genet (2010) 15.52
Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci (2006) 12.23
Cancer statistics, 2002. CA Cancer J Clin (2002) 10.79
Management of cutaneous melanoma. N Engl J Med (2004) 9.52
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol (2004) 5.37
The DNA sequence of human chromosome 7. Nature (2003) 3.18
New IBD genetics: common pathways with other diseases. Gut (2011) 2.95
Tight junctions and the modulation of barrier function in disease. Histochem Cell Biol (2008) 2.13
The claudins. Genome Biol (2009) 1.76
BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants. J Neuropathol Exp Neurol (2012) 1.60
The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis. Proc Natl Acad Sci U S A (2006) 1.54
Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene (2006) 1.53
Cranial irradiation after surgical excision of brain metastases in melanoma patients. Ann Surg Oncol (1996) 1.48
Galpha12 regulates protein interactions within the MDCK cell tight junction and inhibits tight-junction assembly. J Cell Sci (2008) 1.41
Biologic functions of the G12 subfamily of heterotrimeric g proteins: growth, migration, and metastasis. Biochemistry (2007) 1.39
Network modeling of the transcriptional effects of copy number aberrations in glioblastoma. Mol Syst Biol (2011) 1.26
The biology of melanoma brain metastasis. Cancer Metastasis Rev (1999) 1.21
Transmigration of melanoma cells through the blood-brain barrier: role of endothelial tight junctions and melanoma-released serine proteases. PLoS One (2011) 1.11
Role of G12 proteins in oncogenesis and metastasis. Br J Pharmacol (2009) 1.05
Blood-brain barrier integrity and breast cancer metastasis to the brain. Patholog Res Int (2010) 1.05
Galpha12 regulates epithelial cell junctions through Src tyrosine kinases. Am J Physiol Cell Physiol (2003) 1.02
Src kinase inhibitors: promising cancer therapeutics? Crit Rev Oncog (2012) 1.01
Dedifferentiation and decreased expression of adhesion molecules, E-cadherin and ZO-1, in colorectal cancer are closely related to liver metastasis. J Exp Clin Cancer Res (2003) 1.00
Genetics of melanoma. Front Genet (2013) 0.91
miRNA-mediated relationships between Cis-SNP genotypes and transcript intensities in lymphocyte cell lines. PLoS One (2012) 0.90
Novel BRAF Alteration in a Sporadic Pilocytic Astrocytoma. Case Rep Med (2012) 0.89
Tight junction-associated signaling pathways modulate cell proliferation in uveal melanoma. Invest Ophthalmol Vis Sci (2011) 0.86
Neoplastic transformation by the gep oncogene, Galpha12, involves signaling by STAT3. Oncogene (2006) 0.86
Novel somatic mutations in heterotrimeric G proteins in melanoma. Cancer Biol Ther (2010) 0.86
Genes for the CPE receptor (CPETR1) and the human homolog of RVP1 (CPETR2) are localized within the Williams-Beuren syndrome deletion. Genomics (1998) 0.85
KIAA1549-BRAF fusions and IDH mutations can coexist in diffuse gliomas of adults. Brain Pathol (2012) 0.85
Walker 256 tumour cells increase substance P immunoreactivity locally and modify the properties of the blood-brain barrier during extravasation and brain invasion. Clin Exp Metastasis (2012) 0.82
Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia? Med Hypotheses (2011) 0.82
Chromosome 7 aneusomy. A marker for metastatic melanoma? Expression of the epidermal growth factor receptor gene and chromosome 7 aneusomy in nevi, primary malignant melanomas and metastases. Neoplasia (2001) 0.81
A stress-sensitive reporter predicts longevity in isogenic populations of Caenorhabditis elegans. Nat Genet (2005) 3.29
Cumulative deficits better characterize susceptibility to death in elderly people than phenotypic frailty: lessons from the Cardiovascular Health Study. J Am Geriatr Soc (2008) 2.94
Cumulative index of health deficiencies as a characteristic of long life. J Am Geriatr Soc (2007) 1.68
Stochastic model for analysis of longitudinal data on aging and mortality. Math Biosci (2006) 1.61
Cumulative index of elderly disorders and its dynamic contribution to mortality and longevity. Rejuvenation Res (2007) 1.53
Health decline, aging and mortality: how are they related? Biogerontology (2007) 1.45
Accelerated accumulation of health deficits as a characteristic of aging. Exp Gerontol (2007) 1.29
Cancer in rodents: does it tell us about cancer in humans? Nat Rev Cancer (2005) 1.27
Insights on aging and exceptional longevity from longitudinal data: novel findings from the Framingham Heart Study. Age (Dordr) (2006) 1.24
Heritability estimates of endophenotypes of long and health life: the Long Life Family Study. J Gerontol A Biol Sci Med Sci (2010) 1.22
Cumulative deficits and physiological indices as predictors of mortality and long life. J Gerontol A Biol Sci Med Sci (2008) 1.20
Hospital readmission among older adults who return home with unmet need for ADL disability. Gerontologist (2012) 1.20
Age trajectories of physiological indices in relation to healthy life course. Mech Ageing Dev (2011) 1.17
Joint influence of small-effect genetic variants on human longevity. Aging (Albany NY) (2010) 1.16
Body mass index and nine-year mortality in disabled and nondisabled older U.S. individuals. J Am Geriatr Soc (2007) 1.16
Trade-off between cancer and aging: what role do other diseases play? Evidence from experimental and human population studies. Mech Ageing Dev (2008) 1.10
Exceptional survivors have lower age trajectories of blood glucose: lessons from longitudinal data. Biogerontology (2009) 1.07
Maintaining physiological state for exceptional survival: What is the normal level of blood glucose and does it change with age? Mech Ageing Dev (2009) 1.07
What age trajectories of cumulative deficits and medical costs tell us about individual aging and mortality risk: Findings from the NLTCS-Medicare data. Mech Ageing Dev (2008) 1.06
The role of lipid-related genes, aging-related processes, and environment in healthspan. Aging Cell (2013) 1.05
New age patterns of survival improvement in Sweden: do they characterize changes in individual aging? Mech Ageing Dev (2002) 1.05
Genetic model for longitudinal studies of aging, health, and longevity and its potential application to incomplete data. J Theor Biol (2009) 1.04
Trade-off in the effects of the apolipoprotein E polymorphism on the ages at onset of CVD and cancer influences human lifespan. Aging Cell (2011) 1.03
Individual aging and mortality rate: how are they related? Soc Biol (2003) 1.03
Model of hidden heterogeneity in longitudinal data. Theor Popul Biol (2007) 1.03
Association between APOE epsilon 2/epsilon 3/epsilon 4 polymorphism and disability severity in a national long-term care survey sample. Age Ageing (2008) 1.03
Leukocyte telomere length is associated with disability in older u.s. Population. J Am Geriatr Soc (2010) 1.02
Insufficient help for activity of daily living disabilities and risk of all-cause hospitalization. J Am Geriatr Soc (2012) 1.01
Genetic dissection of late-life fertility in Caenorhabditis elegans. J Gerontol A Biol Sci Med Sci (2011) 1.01
"Predicting" parental longevity from offspring endophenotypes: data from the Long Life Family Study (LLFS). Mech Ageing Dev (2010) 1.01
Trade-offs between cancer and other diseases: do they exist and influence longevity? Rejuvenation Res (2010) 0.98
Sex-specific health deterioration and mortality: the morbidity-mortality paradox over age and time. Exp Gerontol (2008) 0.96
The accuracy of statistical estimates in genetic studies of aging can be significantly improved. Biogerontology (2006) 0.94
How lifespan associated genes modulate aging changes: lessons from analysis of longitudinal data. Front Genet (2013) 0.94
Evaluation of genotype-specific survival using joint analysis of genetic and non-genetic subsamples of longitudinal data. Biogerontology (2010) 0.94
Dynamic determinants of longevity and exceptional health. Curr Gerontol Geriatr Res (2010) 0.92
A centenarian-only approach for assessing gene-gene interaction in human longevity. Eur J Hum Genet (2002) 0.92
Beta2-adrenergic receptor gene polymorphisms as systemic determinants of healthy aging in an evolutionary context. Mech Ageing Dev (2010) 0.92
How genes influence life span: the biodemography of human survival. Rejuvenation Res (2012) 0.89
Polygenic effects of common single-nucleotide polymorphisms on life span: when association meets causality. Rejuvenation Res (2012) 0.89
Projected use of long-term-care services by enrolled Veterans. Gerontologist (2007) 0.89
Polymorphisms in the ACE and ADRB2 genes and risks of aging-associated phenotypes: the case of myocardial infarction. Rejuvenation Res (2010) 0.89
Health-protective and adverse effects of the apolipoprotein E epsilon2 allele in older men. J Am Geriatr Soc (2008) 0.88
Do gender, disability, and morbidity affect aging rate in the LLFS? Application of indices of cumulative deficits. Mech Ageing Dev (2011) 0.88
Changes in health status among participants of the Framingham Heart Study from the 1960s to the 1990s: application of an index of cumulative deficits. Ann Epidemiol (2008) 0.87
How the quality of GWAS of human lifespan and health span can be improved. Front Genet (2013) 0.84
Trade-off in the effect of the APOE gene on the ages at onset of cardiocascular disease and cancer across ages, gender, and human generations. Rejuvenation Res (2013) 0.83
Effects of phentermine and phenformin on biomarkers of aging in rats. Gerontology (2004) 0.83
Health-related phenotypes and longevity in danish twins. J Gerontol A Biol Sci Med Sci (2009) 0.83
Modeling hematopoietic system response caused by chronic exposure to ionizing radiation. Radiat Environ Biophys (2011) 0.83